Ophthal Medical News about vitreoretinal surgery

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Doctors and the DEA Free full text

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Comparison of macular function and visual fields after membrane blue or infracyanine green staining in vitreoretinal surgery
Graefe's Archive for Clinical and Experimental Ophthalmology, 10/20/09

Schmid–Kubista KE et al. – Although there was a significant difference in visual fields between the groups after 3 months in the superior region, there were no more significant differences between the two groups after 6 months. However, due to the decrease in the temporal visual field in some eyes, authors conclude that membrane blue is less toxic.

<< Previous
Ophthalmological screening of a paediatric cochlear implant...

Next >>
Sequential Glaucoma Implants in Refractory Glaucoma

Day 1 postoperative intraocular pressure spike in vitreoretinal surgery (VDOP1)
Acta Ophthalmologica, 11/11/09 Relevance Score: 66%

Anterior segment surgery in a standard hospital: an evaluation
Spektrum der Augenheilkunde, 10/01/09 Relevance Score: 66%

Pars plana vitrectomy for vitreoretinal complications of ocular toxoplasmosis
European Journal of Ophthalmology, 11/11/09 Relevance Score: 65%

Intravitreal gas injection for macular hole with localized retinal detachment in highly myopic patients
Acta Ophthalmologica, 10/14/09 Relevance Score: 64%

Chemoradiotherapy for locally advanced head and neck cancer: 10-year follow-up of the UK Head and Neck (UKHAN1) trial
The Lancet Oncology - Online First, 10/30/09 Relevance Score: 46%